The gain for the three months ending Dec. 31 compared with net income of $23.8 million in the same period in 2021 and was largely due to an improved investment performance which more than doubled on the year to total $118.1 million.
The overall performance, which featured an operating loss of $61.6 million, was dragged down by increased expenses that totaled $1.7 billion, up 5.3 percent on 2021.
The system, which operates the 1,541-licensed-bed Yale New Haven Hospital, had total long-term debt of $1.4 billion at the end of 2022. Yale New Haven Health has 2,681 licensed beds overall.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
